PureTech Health (PRTC) Preferred Shares (2020 - 2022)
PureTech Health (PRTC) reported Preferred Shares of -$146.7 million for Q4 2022, down 184.29% year-over-year from $174.0 million in Q4 2021, and down 184.29% on a QoQ basis from $174.0 million in Q4 2021.
PureTech Health (PRTC) has 3 years of Preferred Shares data on file, last reported at -$146.7 million in Q4 2022.
- Quarterly Preferred Shares fell 184.29% year-over-year to -$146.7 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$146.7 million (down 184.29% YoY) and the FY2022 annual result came in at -$146.7 million, down 184.29% from the prior year.
- Preferred Shares retreated to -$146.7 million in Q4 2022 per PRTC's latest filing, from $174.0 million in the prior quarter.
- Across five years, Preferred Shares topped out at $174.0 million in Q4 2021 and bottomed at -$146.7 million in Q4 2022.
- The 3-year median for Preferred Shares is $119.0 million (2020), against an average of $48.8 million.
- The widest annual swing landed in 2021, when Preferred Shares jumped 46.27%; it then tumbled 184.29% in 2022.
- Tracing PRTC's Preferred Shares over 3 years: stood at $119.0 million in 2020, then soared by 46.27% to $174.0 million in 2021, then plunged by 184.29% to -$146.7 million in 2022.
- Per Business Quant, the three latest PRTC Preferred Shares figures stand at -$146.7 million (Q4 2022), $174.0 million (Q4 2021), and $119.0 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -146.68 Mn |
| Dec 31, 2021 | 174.02 Mn |
| Dec 31, 2020 | 118.97 Mn |